Civic Intelligence

Phages for Global Health

EIN 81-1720247 • 501(c)3 • Oakland, CA

Profile

Facilitating phage research in lower- and middle-income countries to combat antibiotic resistance

383 62nd StreetOakland, CA 94618

www.phagesforglobalhealth.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

62nd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

88th percentile

44%

Higher net margin than 88% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

94th percentile

$55,000

Higher top officer pay than 94% of similar nonprofits.

Top officer pay equals 36.1% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

89th percentile

70%

Faster asset growth than 89% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

86th percentile

59%

Faster revenue growth than 86% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets60th percentile

Assets

Up

$164,979

Up $67,772 (+70%) from 2023

Liabilities

Flat

$0

Flat from 2023

Net Assets

Up

$164,979

Up $67,772 (+70%) from 2023

Operations
Liabilities / Revenue62nd percentileNet Margin88th percentile

Revenue

Up

$152,325

Up $56,488 (+59%) from 2023

Expenses

Down

$84,553

Down $33,926 (-29%) from 2023

Net Income

Up

$67,772

Up $90,414 (+399%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth89th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$200K$150K$100K$50K$0Assets 2019: $63,144Liabilities 2019: $02019Assets 2020: $76,925Liabilities 2020: $02020Assets 2021: $104,343Liabilities 2021: $0Net Assets 2021: $104,3432021Assets 2022: $119,849Net Assets 2022: $119,8492022Assets 2023: $97,207Liabilities 2023: $0Net Assets 2023: $97,2072023Assets 2024: $164,979Liabilities 2024: $0Net Assets 2024: $164,9792024

Highlighted filing

2024

Assets$164,979
Liabilities$0
Net Assets$164,979
Open 2024 Filing

Operations Trend

Revenue Growth86th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$200K$150K$100K$50K$0-$50KRevenue 2019: $97,496Expenses 2019: $77,303Net Income 2019: $20,1932019Revenue 2020: $66,780Expenses 2020: $56,124Net Income 2020: $10,6562020Revenue 2021: $77,172Expenses 2021: $46,629Net Income 2021: $30,5432021Revenue 2022: $101,513Expenses 2022: $86,007Net Income 2022: $15,5062022Revenue 2023: $95,837Expenses 2023: $118,479Net Income 2023: -$22,6422023Revenue 2024: $152,325Expenses 2024: $84,553Net Income 2024: $67,7722024

Highlighted filing

2024

Revenue$152,325
Expenses$84,553
Net Income$67,772
Open 2024 Filing

Filings

Most recent year

2024 • Form 990EZXML pending. An XML filing is linked for this year, but detailed extraction is still pending.

Open filing
Assets
$164,979
Liabilities
$0
Net assets
$164,979
Revenue
$152,325
Expenses
$84,553
Net income
$67,772
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.65$0.00$1.65$1.52$0.85$0.68
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.97$0.00$0.97$0.96$1.18$0.23
2022Detailed filing. Detailed filing data is available for this year.$1.20$1.20$1.02$0.86$0.16
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.04$0.00$1.04$0.77$0.47$0.31
2020Summary only. Only limited summary data is available for this year.$0.77$0.00$0.67$0.56$0.11
2019Summary only. Only limited summary data is available for this year.$0.63$0.00$0.97$0.77$0.20
Latest Detailed Filing

The latest 2024 filing currently has linked XML that has not been fully parsed yet. Showing the latest detailed filing from 2022 below.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Nov 9, 2023
Return Version
2022v5.0
Gross Receipts
$101,513
Mission and Program Overview

Mission

Facilitating phage research in developing countries to combat antibiotic resistance.

Facilitating phage research in lower- and middle-income countries to combat antibiotic resistance

Program Services

DescriptionGrantsExpenses
Southeast Asia Phage Workshop: delivered our first virtual training workshop, which included 38 participants from Indonesia, Malaysia, Philippines, Thailand and Vietnam, and 23 instructors from 11 countries$37,864$37,864
Regulatory Considerations for Phages: collated information from national drug regulatory agencies in the US, Europe and Australia to share with regulatory leaders in Africa and Asia$6,563$6,563
Product Development Projects: worked with three international teams to develop phage products for diseases that primarily impact lower- and middle-income countries$3,437$3,437
Compensation and Service Providers
Top Officer Pay94th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Tobi Elaine Nagel PhDPresidentFT$50,000-$50,000
Karen EricksonTreasurer-$0--
James Barnabas LinSecretary-$0--
Filing and Contact Details

Filer

Filer Name
Phages for Global Health
EIN
81-1720247
Phone
6508885522
Address
383 62nd Street, Oakland, CA 94618

Signing Officer

Name
Tobi Nagel
Title
President
Phone
6508885522
Signed
2023-11-09
Supplemental Narrative

Additional Explanations

Part I, Line 16

“Other expenses: - Southeast Asia Phage Workshop Administration: $3981 - General Administrative Expenses: 1295 - Conferences: 1105 - Banking & Accounting Fees: 668”

Raw XML Appendix170 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0Tobi Nagel
IRS990EZ/BooksInCareOfDetail/PhoneNum06508885522
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0383 62nd Street
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Oakland
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd094618
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0104343
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0119849
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/CntrctRcvdGreaterThan100KCnt00
IRS990EZ/ContributionsGiftsGrantsEtcAmt0101513
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt015506
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt025133
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0104343
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0119849
IRS990EZ/GrossReceiptsAmt0101513
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LandAndBuildingsGrp/BOYAmt00
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0104343
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0119849
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0104343
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0119849
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt040.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt050000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Tobi Elaine Nagel PhD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Karen Erickson
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2James Barnabas Lin
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Secretary
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/BOYAmt00
IRS990EZ/OtherEmployeePaidOver100kCnt00
IRS990EZ/OtherExpensesTotalAmt07049
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0Facilitating phage research in lower- and middle-income countries to combat antibiotic resistance
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Southeast Asia Phage Workshop: delivered our first virtual training workshop, which included 38 participants from Indonesia, Malaysia, Philippines, Thailand and Vietnam, and 23 instructors from 11 countries
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1Regulatory Considerations for Phages: collated information from national drug regulatory agencies in the US, Europe and Australia to share with regulatory leaders in Africa and Asia
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt2Product Development Projects: worked with three international teams to develop phage products for diseases that primarily impact lower- and middle-income countries
IRS990EZ/ProgramSrvcAccomplishmentGrp/ForeignGrantsInd0X
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt037864
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt16563
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt23437
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt037864
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt16563
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt23437
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt053825
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt086007
IRS990EZ/TotalProgramServiceExpensesAmt047864
IRS990EZ/TotalRevenueAmt0101513
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0https://www.phagesforglobalhealth.org/
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0101513
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt077172
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt066780
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt097496
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt067339
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0410300
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt00
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt00
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/OtherIncome170Grp/TotalAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.85630
IRS990ScheduleA/PublicSupportPY170Pct00.81190
IRS990ScheduleA/PublicSupportTotal170Amt0351330
IRS990ScheduleA/SubstantialContributorsTotAmt058970
IRS990ScheduleA/SupportedOrganizationsCnt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0101513
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt077172
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt066780
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt097496
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt067339
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0410300
IRS990ScheduleA/TotalSupportAmt0410300
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Other expenses: - Southeast Asia Phage Workshop Administration: $3981 - General Administrative Expenses: 1295 - Conferences: 1105 - Banking & Accounting Fees: 668
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Part I, Line 16
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/PersonNm0Tobi Nagel
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President
ReturnHeader/BusinessOfficerGrp/PhoneNum06508885522
ReturnHeader/BusinessOfficerGrp/SignatureDt02023-11-09
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PHAGES FOR GLOBAL HEALTH
ReturnHeader/Filer/BusinessNameControlTxt0PHAG
ReturnHeader/Filer/EIN0811720247
ReturnHeader/Filer/PhoneNum06508885522
ReturnHeader/Filer/USAddress/AddressLine1Txt0383 62nd Street
ReturnHeader/Filer/USAddress/CityNm0Oakland
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd094618
ReturnHeader/ReturnTs02023-11-09T02:20:17Z
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02022-01-01
ReturnHeader/TaxPeriodEndDt02022-12-31
ReturnHeader/TaxYr02022

Document Assets

No mirrored PDF or thumbnail assets are attached yet.